Home LiteratureArticle Details
PMID: 2677672 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

c-ras-Ha gene expression is regulated by insulin or insulinlike growth factor and by epidermal growth factor in murine fibroblasts.

Molecular and cellular biology ·Vol. 9 ·No. 8 ·1989-08-00 ·Pages 3411-7

Lu KH, Levine RA, Campisi J

Abstract

Although much is known about the structure of ras-encoded proteins, little is known about how expression is regulated. In serum-stimulated murine fibroblasts, c-ras-Ha mRNA levels fluctuated with the growth state but not with the position in the cell cycle. Two types of growth factors regulated c-ras-Ha expression: insulin (IN) or insulinlike growth factor I, each apparently acting through its cognate receptor, and epidermal growth factor (EGF). In quiescent cells, IN or insulinlike growth factor I induced c-ras-Ha mRNA three- to fivefold within 4 h, but thereafter the mRNA declined. By contrast, EGF had little effect in 4 h but induced the mRNA after 4 to 6 h. When quiescent cells were given serum or IN and EGF simultaneously, c-ras-Ha mRNA rose steadily, beginning 1 to 2 h after stimulation, and reached a stable five- to sevenfold elevation in 16 h. Thus, c-ras-Ha gene expression was sequentially regulated by two growth factors, one of which (IN) does not induce expression of other growth-regulated protooncogenes. A transformed derivative cell line that does not require IN for G1 progression has lost early IN-dependent but not late serum-dependent regulation. The results support the possibility that c-ras-Ha and IN action are functionally linked.

MeSH Terms
Animals Blotting, Northern Cell Cycle Cell Line, Transformed Cells, Cultured Epidermal Growth Factor/physiology Fibroblasts/metabolism Gene Expression Regulation Insulin/physiology Insulin-Like Growth Factor I/physiology Mice Proto-Oncogene Proteins/genetics Proto-Oncogene Proteins p21(ras) RNA, Messenger/analysis,biosynthesis Somatomedins/physiology
Chemicals
Insulin Proto-Oncogene Proteins RNA, Messenger Somatomedins Epidermal Growth Factor Insulin-Like Growth Factor I Proto-Oncogene Proteins p21(ras)
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Lu K H
Department of Biochemistry, Boston University School of Medicine, Massachusetts 02118.
Levine R A
Campisi J
References (37)
37 references, click to expand
  1. Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact.
    J Biol Chem. 1986 Jul 15;261(20):9161-6 PMID: 3722193
  2. A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene.
    Nature. 1988 Jul 14;334(6178):119-24 PMID: 3133569
  3. Induction of c-fos and c-myc mRNA by epidermal growth factor or calcium ionophore is cAMP dependent.
    Proc Natl Acad Sci U S A. 1986 Nov;83(21):8216-20 PMID: 2430281
  4. Activation of proto-oncogene expression by growth regulatory signals.
    Curr Top Microbiol Immunol. 1986;132:313-9 PMID: 3491738
  5. Two independent growth factor-generated signals regulate c-fos and c-myc mRNA levels in Swiss 3T3 cells.
    J Biol Chem. 1987 Feb 5;262(4):1442-5 PMID: 3492494
  6. Ras p21 as a potential mediator of insulin action in Xenopus oocytes.
    Science. 1987 May 15;236(4803):840-3 PMID: 3554510
  7. Molecular cloning of gene sequences that are regulated by insulin-like growth factor I.
    J Biol Chem. 1987 Aug 15;262(23):11252-60 PMID: 3611109
  8. ras genes.
    Annu Rev Biochem. 1987;56:779-827 PMID: 3304147
  9. High-level expression of c-H-ras1 fails to fully transform rat-1 cells.
    Mol Cell Biol. 1988 Apr;8(4):1460-8 PMID: 3288862
  10. Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40.
    J Cell Physiol. 1968 Oct;72(2):141-8 PMID: 4301006
  11. Changes in the uptake of 2-deoxy-D-glucose in BALB-3T3 cells chemically transformed in culture.
    J Cell Physiol. 1974 Apr;83(2):193-201 PMID: 4822526
  12. S phase synchrony in monolayer CHO cultures.
    Exp Cell Res. 1976 Jul;100(2):265-75 PMID: 939252
  13. Insulin receptors in normal and transformed fibroblasts: relationship to growth and transformation.
    Cell. 1976 Jul;8(3):417-23 PMID: 954096
  14. Control of growth of benzo(a)pyrene-transformed 3T3 cells.
    Proc Natl Acad Sci U S A. 1976 Sep;73(9):3229-32 PMID: 184467
  15. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
    Biochemistry. 1979 Nov 27;18(24):5294-9 PMID: 518835
  16. Ligand: a versatile computerized approach for characterization of ligand-binding systems.
    Anal Biochem. 1980 Sep 1;107(1):220-39 PMID: 6254391
  17. Restriction point control of cell growth by a labile protein: evidence for increased stability in transformed cells.
    Proc Natl Acad Sci U S A. 1982 Jan;79(2):436-40 PMID: 6952194
  18. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus.
    Nature. 1982 Jun 10;297(5866):479-83 PMID: 6283358
  19. Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells.
    Exp Cell Res. 1982 Sep;141(1):107-15 PMID: 6749535
  20. Epidermal growth factor: mechanisms of action.
    Int Rev Cytol. 1982;78:233-56 PMID: 6292122
  21. Cell cycle perturbations in normal and transformed fibroblasts caused by detachment from the substratum.
    J Cell Physiol. 1983 Jan;114(1):53-60 PMID: 6186678
  22. Interactions of a monoclonal antibody to the insulin receptor with receptors for insulin-like growth factors.
    Endocrinology. 1983 May;112(5):1865-7 PMID: 6299712
  23. Cellular oncogenes and retroviruses.
    Annu Rev Biochem. 1983;52:301-54 PMID: 6351725
  24. Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cells.
    Exp Cell Res. 1983 Aug;147(1):202-8 PMID: 6604639
  25. The role of protein kinase C in cell surface signal transduction and tumour promotion.
    Nature. 1984 Apr 19-25;308(5961):693-8 PMID: 6232463
  26. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.
    Nature. 1984 Aug 9-15;310(5977):508-11 PMID: 6611509
  27. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells.
    Cell. 1984 Aug;38(1):109-17 PMID: 6380758
  28. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene.
    Nature. 1984 Oct 4-10;311(5985):433-8 PMID: 6090941
  29. Post-transcriptional control of the onset of DNA synthesis by an insulin-like growth factor.
    Mol Cell Biol. 1984 Sep;4(9):1807-14 PMID: 6387447
  30. Homologies between signal transducing G proteins and ras gene products.
    Science. 1984 Nov 16;226(4676):860-2 PMID: 6436980
  31. Induction of c-fos gene and protein by growth factors precedes activation of c-myc.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):716-20 PMID: 6334806
  32. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.
    Nature. 1985 Jan 17-23;313(5999):241-3 PMID: 3918269
  33. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.
    Nature. 1985 Feb 28-Mar 6;313(6005):756-61 PMID: 2983222
  34. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling.
    Cell. 1985 Apr;40(4):747-58 PMID: 2859121
  35. Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts.
    Proc Natl Acad Sci U S A. 1986 Feb;83(3):664-8 PMID: 3003744
  36. Ras p21 proteins with high or low GTPase activity can efficiently transform NIH/3T3 cells.
    Cell. 1986 Feb 28;44(4):609-17 PMID: 3004741
  37. ras gene Amplification and malignant transformation.
    Mol Cell Biol. 1985 Oct;5(10):2836-41 PMID: 3915535
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1989-08-00
Pages
3411-7
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC362387
Subset
IM
Grants
NCI NIH HHS · CA45695 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com